Diagnosis

Esophageal cancer

Cancer in the esophagus.

Etiology

Cause [b4o]

Pathophysiology [b4o]

  1. In squamous cell carcinoma:

    • Genetic, environmental, and lifestyle factors (smoking, alcohol, hot beverages, and poor nutrition)

  2. In adenocarcinoma:

    • Repeated exposure to stomach acid --> replacement of the normal squamous epithelium with metaplastic columnar epithelium (Barrett esophagus)

  3. Chronic irritation/inflammation + exposure to carcinogens

  4. Genetic alterations --> mutations in tumor suppressor genes (p53) and oncogenes

  5. Disruption of normal cell cycle regulation --> promoting uncontrolled cell growth

  6. Dysplasia --> carcinoma in situ (cancer cells are confined to the epithelial layer)

  7. Cancer cells breach the basement membrane and invade the submucosa and muscularis propria --> Cancer

  8. Cancer cells enter the lymphatic system or bloodstream --> metastasis to lymph nodes, the liver, lungs, and bones

Risk factors [b4o]

Complications [b4o]

Epidemiology

Incidence per 100.000 [akg]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Aphonia, Cachexia, Cough, Dysphagia, Globus sensation, Hematemesis, Hemoptysis, Hoarseness, Lymphadenopathy, Melena, Nausea, Odynophagia, Stridor, Vomiting, Weight loss

Clinical findings

Anemia, Elevated Sedimentation Rate, Esophageal stricture, Esophageal ulcer

Anamneses

None listed.

Localized findings

Pain
Radiates
CollumRetrosternal
Onset
Gradual (days)
Pattern
Constant
Provoked by
Postprandial
Severity
Mild (1-3)Moderate (4-7)

Approach

TNM-classification

Treatment

  1. Early-stage: T1a or superficial cT1b [b4o]

    • Endoscopic resection

  2. Mid-stage: lesions penetrating the submucosa with negative lymph nodes (<3 cm)

    • Esophagectomy with lymphadenectomy

  3. Local lymph node-positive:

    • Esophagectomy + neoadjuvant chemo(radio)therapy

  4. Advanced: T4a or T4b

    • Definitive chemoradiation

  5. Palliative stage:

    • Chemotherapy

    • Radiotherapy

    • Brachytherapy

    • Stents (treatment of dysphagia)

Differential diagnoses

Achalasia, Eosinophilic esophagitis, Esophageal diverticula, Esophageal perforation, Esophageal spasm, Esophageal stricture, Gastric cancer, Gastroesophageal reflux disease, Lipoleiomyoma, Myasthenia gravis, Pneumonia, Systemic sclerosis, Tuberculosis


References

[1] Wang Y, Mukkamalla SKR, Singh R, et al. Esophageal Cancer. [Updated 2024 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459267/

[2] Liu CQ, Ma YL, Qin Q, Wang PH, Luo Y, Xu PF, Cui Y. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac Cancer. 2023 Jan;14(1):3-11.

[3] New York State Cancer Registry: https://www.health.ny.gov/statistics/cancer/registry/table6/tb6esophagusupstate.htm

[4] Al-Kaabi, A., Baranov, N. S., van der Post, R. S., Schoon, E. J., Rosman, C., van Laarhoven, H. W. M., … Siersema, P. D. (2022). Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study. Acta Oncologica, 61(5), 545–552.

[5] Jiang Y, Lin Y, Wen Y, Fu W, Wang R, He J, Zhang J, Wang Z, Ge F, Huo Z, Wang R, Peng H, Wu X, He J, Li S. Global trends in the burden of esophageal cancer, 1990-2019: results from the Global Burden of Disease Study 2019. J Thorac Dis. 2023 Feb 28;15(2):348-364.

Scroll to top